Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 81.99M
March 31, 2026 77.45M
December 31, 2025 74.51M
September 30, 2025 85.27M
June 30, 2025 77.04M
March 31, 2025 70.35M
December 31, 2024 67.07M
September 30, 2024 89.84M
June 30, 2024 114.61M
March 31, 2024 98.75M
December 31, 2023 92.49M
September 30, 2023 91.15M
June 30, 2023 81.28M
March 31, 2023 77.24M
December 31, 2022 78.42M
September 30, 2022 86.28M
June 30, 2022 91.25M
March 31, 2022 92.85M
December 31, 2021 95.48M
September 30, 2021 97.18M
June 30, 2021 93.21M
March 31, 2021 93.10M
December 31, 2020 95.53M
September 30, 2020 91.97M
June 30, 2020 91.34M
Date Value
March 31, 2020 81.75M
December 31, 2019 75.18M
September 30, 2019 78.89M
June 30, 2019 81.57M
March 31, 2019 84.88M
December 31, 2018 80.34M
September 30, 2018 75.86M
June 30, 2018 79.24M
March 31, 2018 75.55M
December 31, 2017 67.18M
September 30, 2017 63.88M
June 30, 2017 58.77M
March 31, 2017 53.03M
December 31, 2016 42.20M
September 30, 2016 40.23M
June 30, 2016 36.63M
March 31, 2016 33.79M
December 31, 2015 26.05M
September 30, 2015 32.38M
June 30, 2015 29.71M
March 31, 2015 21.13M
December 31, 2014 21.07M
September 30, 2014 19.92M
June 30, 2014 11.82M
March 31, 2014 10.98M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 1.676B
Merck & Co., Inc. 7.182B
ANI Pharmaceuticals, Inc. 375.87M
Corcept Therapeutics, Inc. 308.20M
Veru, Inc. 25.79M